Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2011
11/02/2011EP2382208A1 Insecticidal compounds
11/02/2011EP2382207A2 Pi3k/mtor kinase inhibitors
11/02/2011EP2382202A1 Dihydropyridone amides as p2x7 modulators
11/02/2011EP2382197A1 Modulators of cystic fibrosis transmembrane conductance regulator
11/02/2011EP2382195A1 Substituted amidine compounds for combating animal pests
11/02/2011EP2382190A1 Toluidine sulfonamides and their use as-inhibitors
11/02/2011EP2381778A1 C5ar antagonists
11/02/2011EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011EP2222668B1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
11/02/2011EP2185550B1 Substituted aryloxazoles and the use thereof
11/02/2011EP2114931B1 Piperidine gpcr agonists
11/02/2011EP1758883B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
11/02/2011CN102229606A 2-methylbenzofuran derivative containing isoxazole heterocycle, and preparation method and application thereof
11/02/2011CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011CN102229604A Preparation and synthetic method for chiral oxazoline
11/02/2011CN102229578A Preparation method of 2-arylamino-1,3,4-oxadiazole compound
11/02/2011CN101648921B Benzamide compound used as histone deacetylase inhibitor and application thereof
11/02/2011CN101490021B Insecticidal compounds
11/02/2011CN101058573B 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
11/01/2011USRE42890 Furazanobenzimidazoles
11/01/2011US8049017 Preparation of isoxazolin-3-ylacylbenzenes
11/01/2011US8049010 Using 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-formaldehyde as raw material; cyanation to 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-acrylonitrile; carbonylation, chain extension, hydrolysis, neutralization, decomposition, catalysis
11/01/2011US8048901 5-{3-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxy)cyclohexyloxy]-propyl}-2H-tetrazole; metabolic disorders, insulin resistance, dyslipidemia, Syndrome X
11/01/2011US8048899 Compounds which selectively modulate the CB2 receptor
11/01/2011US8048898 Inhibitor of binding of S1P1
11/01/2011US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011US8048874 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
11/01/2011CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011CA2645257C Sulfonyl benzimidazole derivatives
11/01/2011CA2640435C Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
11/01/2011CA2629462C Beta-secretase modulators and methods of use
11/01/2011CA2535749C Ppar activating compound and pharmaceutical composition containing same
11/01/2011CA2521854C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
11/01/2011CA2479012C Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
11/01/2011CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011CA2404938C Production of polyketides
10/2011
10/27/2011WO2011133734A1 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists
10/27/2011WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011WO2011131741A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
10/27/2011US20110263865 Polymorphs of zolmitriptan
10/27/2011US20110263864 Regeneration of 2,2'-cyclopropylidene-bis (oxazolines)
10/27/2011US20110263845 Method for manufacturing heterocycle substituted pyridine derivatives
10/27/2011US20110263663 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/27/2011US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011US20110263620 Quinoline compounds and their use for treating viral infection
10/27/2011US20110263614 Novel compounds
10/27/2011US20110263613 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
10/27/2011US20110263612 Compounds that modulate intracellular calcium
10/27/2011US20110263603 Imine Compounds for Combating Invertebrate Pests
10/27/2011US20110263602 Tetrasubstituted pyridazine hedgehog pathway antagonists
10/27/2011US20110263599 7-nonsubstituted indole mcl-1 inhibitors
10/27/2011US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011US20110263584 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011US20110263583 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011US20110263581 Fused tricyclic compounds as serine-threonine protein kinase and parp modulators
10/27/2011US20110263571 Novel amide derivative and use thereof as medicine
10/27/2011US20110263569 Ryanodine channel binders and uses thereof
10/27/2011US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011US20110263565 Compounds
10/27/2011US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011US20110263562 Bicyclic compound
10/27/2011US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011US20110263560 Organic Compounds
10/27/2011US20110263558 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
10/27/2011US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011US20110263532 Halofuginone analogs for inhibition of trna synthetases and uses thereof
10/27/2011US20110263530 Aurora Kinase Modulators and Method of Use
10/27/2011US20110263428 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
10/27/2011US20110262904 Fluorescent dyes,methods of synthesis and applications thereof
10/27/2011US20110260153 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the same
10/27/2011CA2794724A1 Oxazole derivatives useful as modulators of faah
10/26/2011EP2380878A1 Cyclic compound having hetero atom
10/26/2011EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011EP2379749A1 Unsymmetrical cyanine dyes for high resolution nucleic acid melting analysis
10/26/2011EP2379544A1 Isoxazolines derivatives and their use as pesticide
10/26/2011EP2379542A1 Novel oxime derivatives
10/26/2011EP2379541A2 Insecticidal compounds
10/26/2011EP2379540A1 Dipeptoid prodrugs and the use thereof
10/26/2011EP2379539A1 Amino acid ester prodrugs and the use thereof
10/26/2011EP2379538A2 Heterocyclic compounds as phosphodiesterase inhibitors
10/26/2011EP2379537A2 Organic compounds
10/26/2011EP2379535A1 7-phenoxychroman carboxylic acid derivatives
10/26/2011EP2379529A1 Novel compounds
10/26/2011EP2379527A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
10/26/2011EP2379525A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
10/26/2011EP2379524A1 Serotonin 5-ht2b receptor inhibitors
10/26/2011EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011EP2379521A1 Sulfamides as trpm8 modulators
10/26/2011EP2379515A2 Benzoxazole-based fluorescent metal ion indicators
10/26/2011EP2379513A1 Heteroaryl compounds useful as raf kinase inhibitors
10/26/2011EP2379496A1 Sulfonamides as trpm8 modulators
10/26/2011EP2181985B1 Antiviral Agent
10/26/2011EP2057141B1 Pyrimidone compounds as gsk-3 inhibitors
10/26/2011EP1846394B1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/26/2011EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011CN102227423A Fungicidal heterocyclic compounds